BioSpherix was recently chosen as the supplier of choice in providing a modular GMP isolator (cleanroom alternative) for Semma Therapeutics. Cambridge-based Semma is built on research that came out of Doug Melton’s laboratory at the Harvard Stem Cell Institute , and now focuses on developing a delivery system and method of creating transplantable stem cells as a possible cure for Type 1 diabetes. Read more.